baber/WOPTO huggingface dataset:
Patent NZ-598936-A (NZ)
Title: Opposite radial rotary-piston engine
Inventor: CHORONSKI EVGENIY
IPC: F02B75/28
Filed: 2009-08-24
Abstract: 598936 A two-stroke opposite radial rotary-piston engine. It comprises a cylinder block (1) including sleeves (4), and pairs of pistons (6) slidingly disposed within the sleeves (4) and oppositely movable. Each piston (6) bas a rod (8) and a head opposite the rod (8). The engine comprises guiding bearings and a power take-off shaft (20). Two rotors (16, 17) are mounted on the shaft (20), each having an inner surface formed by a closed curved line, with the rotors transverse axes disposed mutually perpendicularly. The engine comprises T-like traverses (7) pair-wise spanning the rods (8) of the pistons (6). Support bearings (10) each include an external bushing capable of rolling over the inner surface of the rotor associated with the traverses (7), thereby impelling the rotor.
Patent NZ-598941-A (NZ)
Title: Isoquinoline modulators of ATP-Binding Cassette transporters
Inventor: HADIDA RUAH SARA
IPC: A61K31/472
Filed: 2008-11-14
Abstract: ABSTRACT - 598941 The disclosure relates to a substituted isoquinoline derivative of the formula (I) and pharmaceutically acceptable salt thereof, wherein the variables are as defined in the specification. These isoquinoline derivatives are useful as modulators of ATPBinding Cassette ("ABC") transporter activity, including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"). Said substituted isoquinoline compound may be suitable for treating ABC transporter mediated diseases selected from cystic fibrosis, asthma, smoke induced COPD, chronic bronchitis, rhinosinusitis, constipation, pancreatitis, pancreatic insufficiency, male infertility caused by congenital bilateral absence of the vas deferens, mild pulmonary disease, idiopathic pancreatitis, allergic bronchopulmonary aspergillosis, liver disease, hereditary emphysema, hereditary hemochromatosis, coagulation-fibrinolysis deficiencies, lipid processing deficiencies, lysosomal storage diseases, Crigler-Najjar type II, polyendocrinopathy/hyperinsulemia, Diabetes mellitus, Laron dwarfism, myeloperoxidase deficiency, primary hypoparathyroidism, melanoma, glycanosis CDG type 1, congenital hyperthyroidism, osteogenesis imperfecta, hereditary hypofibrinogenemia, ACT deficiency, Diabetes insipidus, neurophyseal DI, neprogenic DI, Charcot-Marie Tooth syndrome, Perlizaeus-Merzbacher disease, neurodegenerative diseases several polyglutamine neurological disorders as well as spongiform encephalopathies, COPD, dry-eye disease and Sjogren's disease.
Patent NZ-600138-A (NZ)
Title: Morpholinothiazoles as alpha 7 positive allosteric modulators
Inventor: MACDONALD GREGOR JAMES
IPC: A61K31/427
Filed: 2010-11-25
Abstract: 600138 Disclosed herein is a compound of formula (I), wherein the variables are defined in the specification, and the use thereof in the treatment of psychotic disorders, intellectual impairment disorders and inflammatory diseases. Specific embodiments of a compound of formula (I) include: N-[[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-5-(2,6-dimethyl-4-pyridinyl)-4-thiazolyl]methyl]-cyclopropaneacetamide (Compound 1); N-[[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-5-(2,6-dimethyl-4-pyridinyl)-4-thiazolyl]methyl]-3-methyl-4-isoxazolecarboxamide (Compound 18); N-[[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-5-(2,6-dimethyl-4-pyridinyl)-4-thiazolyl]methyl]-3-methyl-5-isoxazolecarboxamide (Compound 4); and N-[[2-[(2R,6S)-2,6-dimethyl-4-morpholinyl]-5-(2,6-dimethyl-4-pyridinyl)-4-thiazolyl]methyl]-acetamide (Compound 60). Additionally disclosed is a pharmaceutical compositions comprising the compound of formula (I) and an alpha7 nicotinic receptor agonist selected from 1,4-Diazabicyclo[3.2.2]nonane-4-carboxylic acid, 4-bromophenyl ester, monohydrochloride (SSR180711A); (-)-spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidine]-2'-one; (+)-N-(1-azabicyclo[2.2.2]oct-3-yl)benzo[b] furan-2-carboxamide; 3-[(2,4-Dimethoxy)Benzylidene]-Anabaseine Dihydrochloride (GTS-2I); [N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]-4-chlorobenzamide Hydrochloride] PNU-282987; nicotine; varenicline; A-582941; AR-R17779; TC-1698; PHA-709829; tropisetron; WAY-317538; MEM3454; EVP-6124; TC-56I9; MEM-63908; and AZD-0328,
Patent NZ-601150-A (NZ)
Title: Novel substituted bicyclic triazole derivatives as gamma secretase modulators
Inventor: DE CLEYN MICHEL ANNA JOZEF
IPC: A61K31/4196
Filed: 2011-01-12
Abstract: The disclosure relates to substituted bicyclic triazole derivatives of formula (I) wherein the variables Het1, R1, R2, A1, A2, A3, A4, L1, and L2 are as defined in the specification. These substituted bicyclic triazole derivatives are useful as gamma secretase modulators. The disclosure further relates to processes for preparing these compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament. These (-secretase modulators are suitable for use in the treatment or prevention of a disease or condition selected from Alzheimer’s disease, traumatic brain injury, mild cognitive impairment, senility, dementia, dementia with Lewy bodies, cerebral amyloid angiopathy, multi-infarct dementia, dementia pugilistica, Down’s syndrome, dementia associated with Parkinson’s disease and dementia associated with beta-amyloid.
Patent NZ-601666-A (NZ)
Title: Heating structure
Inventor: LEE SANG WON
IPC: F24D3/16
Filed: 2011-01-28
Abstract: A heating structure (100) used for heating a building is disclosed. The heating structure or ondol panel comprises: a heat insulator (110), which is disposed at the top surface of the structure; an under-floor heating panel (200), which is disposed at the top surface of the heat insulator and has an inlet (212) and an outlet (213) for a hot water flow formed inside thereof; a pipe housing (300), which is adapted to have a top surface level with the top of the heat insulator and has a connection pipe receiver (310) inside. A hot water supply pipe (420) is arranged in the connection pipe receiver, with one end being connected to the inlet and the other end being connected to a hot water supplier. With the use of this heating structure, the construction period can be shortened because there is no need to wait until the cement on the floor is cured, and furthermore construction costs can be reduced as well. Moreover, when one of the under-floor heating panels has a water leak, only the corresponding panel having such a problem needs to be replaced, thereby facilitating the maintenance process. The ondol panel includes an upper plate and a lower plate separately manufactured, a passage being formed in each of surfaces of the upper and lower plates to be coupled to each other. The plates are bonded to each other to form the hot water passage directly contacting the hot water.
Patent NZ-617203-A (NZ)
Title: Ectoparasitic treatment method and composition
Inventor: SMITH WARWICK MITCHELL
IPC: A61P33/14
Filed: 2012-09-28
Abstract: The disclosure relates to a method of treating a non-human animal, particularly sheep infested with biting lice of the species Bovicola ovis, wherein the method comprises the step of administering internally to the animal a pharmaceutically effective amount of spinosyn such that the spinosyn reaches multiple areas of a body of the non-human animal, at least in part via the bloodstream such that spinosyn is present systemically within the animal, wherein the spinosyn is spinosad or spinetoram, and wherein the spinosyn is administered in a total dosage of equal to or less than 40 milligrams per kilogram of the animal such that the spinosyn is administered to the animal in the order of two or more 1 to 6 milligrams per kilogram dosages spaced apart by a day or more.
Patent NZ-620810-A (NZ)
Title: Method and system for controlling hydroelectric turbines
Inventor: CAWTHORNE SIMON
IPC: H02P9/48
Filed: 2012-08-10
Abstract: A control system for controlling an operation of a hydroelectric turbine (10) is disclosed. The control system comprises a converter system (20) to convert AC power, supplied by a generator (18) connected to the turbine (16), and having a voltage and frequency that is a function of a rotational speed of the turbine (16), to AC power having a voltage and frequency of a transmission system for transmitting the AC power to a receiving station. The system further comprises a control unit (32) that is arranged to determine an indication of a water flow speed through the turbine and is arranged to co-operate with the converter system to adjust the AC voltage supplied by the generator in response to a water flow speed through the turbine to thereby control rotation of the turbine (16). The converter system comprises a first-stage converter (26) and a second-stage converter (28), with a DC link provided between the first and second-stage converters. The first-stage converter (26) is arranged to convert the AC power supplied by the generator to DC power. The second-stage converter (28) is arranged to convert the DC power to the AC Power for transmission to the receiving station and the second-stage converter (28) is of a voltage-source inverter type.
Patent NZ-705405-A (NZ)
Title: Ventilator and blade therefor
Inventor: MUNN DEREK
IPC: F24F13/00
Filed: 2013-09-09
Abstract: A roof-mounted ventilator comprising a plurality of blades is disclosed. Each blade comprises front and back blade faces and leading and trailing edges. When the ventilator is viewed in side profile, the blades are positioned and configured such that a line of sight into the interior of the ventilator is substantially restricted or obstructed. Restricting or obstructing the line of sight into the ventilator can reduce or prevent various particles, such as water droplets, debris, dust and light, from entering the ventilator interior. For example, rain is thereby forced to strike a face of the blades, thus preventing direct access into the ventilator interior. The blade itself may include additional features, such as a lip that extends along the length of the leading edge, to further prevent particles from entering the ventilator interior, or to redirect the particles away from the ventilator interior in a controlled manner.
Patent NZ-709429-A (NZ)
Title: Rna-guided human genome engineering
Inventor: CHURCH GEORGE M
IPC: C12N15/00
Filed: 2013-12-16
Abstract: A method of altering a eukaryotic cell is provided. The method comprises providing to the eukaryotic cell a guide RNA sequence complementary to a target nucleic acid sequence, wherein the guide RNA sequence binds to the target nucleic acid sequence, and the guide RNA sequence includes a guide sequence complementary to the target nucleic acid sequence and a scaffold sequence connected to the guide sequence, and providing to the eukaryotic cell a Cas9 protein that interacts with the guide RNA sequence.
Patent NZ-710013-A (NZ)
Title: Herbicidal compositions comprising 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl) pyridine-2-carboxylic acid
Inventor: SATCHIVI NORBERT
IPC: A01N43/54
Filed: 2014-01-24
Abstract: Herbicidal compositions and methods using a combination of (a) a compound of formula (I) or an agriculturally acceptable salt or ester thereof and (b) diclosulam or clorasulam-methyl or an agriculturally acceptable salt thereof provide control of undesirable vegetation in, e.g., rice, wheat, barley, oats, rye, sorghum, com or maize, oilseed rape, vegetables, pastures, grasslands, rangelands, fallowland, turf, tree and vine orchards, aquatics, industrial vegetation management or rights-of-way.
Patent NZ-710264-A (NZ)
Title: Apparatus and methods for tar removal from syngas
Inventor: KO CHING-WHAN
IPC: C10K3/00
Filed: 2012-04-04
Abstract: A process and apparatus are provided for reducing content of tar in a tar containing syngas (150). The process includes contacting the tar containing syngas with a molecular oxygen containing gas (250) in a first reaction zone (200) to produce a gas mixture. The gas mixture is passed through a heat treatment zone (300) maintained at a temperature between about 900°C to about 2000°C for a contact time of about 0.5 to about 5 seconds. In this aspect, at least a portion of the tar undergoes at least partial oxidation and/or cracking to produce a hot syngas (450). The ratio of linear velocity (meters/second) to height (meters) of the syngas in the heat treatment zone is about 0.3:12.5 to about 2.0:2.5.
Patent NZ-710337-A (NZ)
Title: Compositions containing chondroitin sulphate, proteolytic enzymes and sulphydryl compounds for improving the bioavailability of chondroitin sulphate
Inventor: MIRAGLIA Niccolò
IPC: A61K38/48
Filed: 2014-01-23
Abstract: The present invention describes combinations comprising chondroitin sulphate (CS), the protease enzyme nattokinase, and sulphydryl compounds, for the treatment and prevention of osteoarthritis and correlated acute and chronic inflammatory processes, or as nutraceutical compositions for the maintenance of musculoskeletal well-being in humans and animals. The characteristic of said combinations is that they increase the intestinal absorption of CS when administered orally. The effect of said combinations is exerted on a wide range of molecular weights of CS, including CS samples with very low molecular weights which already possess greater bioavailability than samples with a higher molecular weight. The effect is exerted on CS samples of any origin.
Patent NZ-711737-A (NZ)
Title: Vehicle suspension system with reservoir for air spring damping
Inventor: DELORENZIS DAMON
IPC: B60G17/056
Filed: 2014-04-01
Abstract: It is known to dampen deflection of a suspension system equipped with air springs. However, in some situations, sufficient volume is not available in an air spring for an internal damping reservoir. In addition, prior designs with internal damping reservoirs have not achieved a desired damping ratio for comfortable and safe vehicle use. In accordance with the present invention, a suspension system can include an air spring, an air reservoir external to the air spring, wherein the air spring has an internal air volume at least 2-1/2 times as great as a volume of the air reservoir, and a flow control device which variably restricts flow of air between the air spring and the air reservoir. Further, a pressure differential between the air spring and the air reservoir acts upon at least one closure member of the flow control device, thereby causing the flow control device to open. The flow control device may permit flow between the air spring and the air reservoir in response to a predetermined pressure differential level across the flow control device. Multiple air reservoirs can be internal to an axle, and can be isolated from each other in the axle. The present invention provides advantages in a reservoir for air spring damping in a suspension system.
Patent NZ-719075-A (NZ)
Title: Double-disc ploughshare comprising an innerlying depth guide
Inventor: BERENDSEN MARK
IPC: A01C7/20
Filed: 2014-10-15
Abstract: The invention addresses problems of blockages between double disc coulters and the depth control wheel and the accompanying braking effects. In each case at least one double disc coulter 7, 8 and one depth control wheel 9 are arranged on the frame 6 of a pneumatic precision seed drill. Seen from the direction of travel, this depth control wheel 9 is located between the two disc coulters 7, 8, whereby the two disc coulters 7, 8 and the depth control wheel 9 rotate in the same direction. The depth control wheel and inner coulters 10 of the two disc coulters are in contact with each other. The axle 36 of the double disc coulter 7, 8 lies inside the circumference of the depth control wheel 9 or the axle 37 of the depth control wheel 9 lies inside the circumference of the double disc coulters 7, 8.
Patent NZ-720331-A (NZ)
Title: Solid pharmaceutical compositions containing an integrase inhibitor
Inventor: MA DECHENG
IPC: A61K31/425
Filed: 2010-10-21
Abstract: Disclosed is a compressed tablet for oral administration, which comprises: (A) an intragranular component comprising: (i) an effective amount of an alkali metal salt of raltegravir, (ii) optionally a first superdisintegrant, and (iii) a binder; and (B) an extragranular component comprising: (i) a second superdisintegrant, (ii) a filler, and (iii) a lubricant; with the proviso that the tablet is free of atazanavir or a pharmaceutically acceptable salt thereof. Compressed tablets for oral administration containing raltegravir in the form of a pharmaceutically acceptable salt are described. The tablets comprise: (A) an intragranular component comprising (i) an effective amount of an alkali metal salt of raltegravir, (ii) optionally a first superdisintegrant, and (iii) a binder; and (B) an extragranular component comprising (i) a second superdisintegrant, (ii) a filler, and (iii) a lubricant. Methods for preparing the tablets and the use of the tablets, optionally in combination with other anti-HIV agents, for the inhibition of HIV integrase, for the treatment or prophylaxis of HIV infection, or for the treatment, delay in the onset, or prophylaxis of AIDS are also described. Raltegravir is also known as N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl).
Patent NZ-721935-A (NZ)
Title: Construction of pipes
Inventor: GRAHAM NEIL DERYCK BRAY
IPC: F16L11/26
Filed: 2011-10-31
Abstract: An elongate hollow structure such as a pipe (10) and a method of constructing such an elongate hollow structure. The pipe comprises a radially inner portion (11) and a radially outer portion (13), with the two portions (11, 13) merging together to provide an integrated tubular wall structure. The method comprises: providing the radially inner portion in the form of an inner tube (21) and assembling the radially outer portion about the inner tube . The outer portion comprises an outer tube of fibre reinforced composite construction surrounded by a flexible outer casing (31). The inner tube is expanded by injecting an inflation fluid into the inner portion from an end of the elongate hollow structure to give form and shape to the outer portion. The elongate hollow structure is compressed at a location distal to an end from which the inflation fluid is injected so that inflation fluid cannot pass through the location distal to the end.
Patent NZ-723974-A (NZ)
Title: Chimeric cd27 receptors for redirecting t cells to cd70-positive malignancies
Inventor: GOTTSCHALK STEPHEN M G
IPC: C07K19/00
Filed: 2011-10-27
Abstract: Disclosed is a chimeric antigen receptor that recognizes the CD70 antigen and that comprises the T-cell receptor CD3-ζ chain and further comprising CD28.
Patent NZ-728313-A (NZ)
Title: Phenyl tetrahydroisoquinoline compound substituted with heteroaryl
Inventor: USHIKI YASUNOBU
IPC: C07D417/10
Filed: 2015-07-24
Abstract: Provided is a compound represented by formula [1] that has NHE3 inhibitory effects, or a pharmaceutically acceptable salt thereof. (In formula [1], A indicates a structure represented by formula [2]. In formula [2], R11 and R12 represent a halogen atom or the like, R2 indicates a C1-6 alkyl or the like, ring E indicates a triazole, a tetrazole, a pyrimidine or the like, R31 and R32 represent a hydrogen atom, a C1-6 alkyl, a C1-6 alkoxy or the like, and W indicates a single bond, a formula -NH-, a formula -O-, or a formula -CONH-. Y indicates a hydrogen atom or a structure represented by formula [3’].)
Patent NZ-730574-A (NZ)
Title: Detection and repair of broken single sign-on integration
Inventor: AGUILAR-MACIAS HECTOR
IPC: H04L29/06
Filed: 2015-09-04
Abstract: An identity management system provides single sign-on (SSO) services to clients, logging the clients into a variety of third-party services for which the clients have accounts. An SSO integration is stored for each of the third-party services, the SSO integration including information that allows the identity management system to automate the login for the corresponding third-party service, such as locations of the login pages, and/or identities of username and password fields. The identity management system uses different techniques in different embodiments to detect that a given SSO integration is broken (i.e., no longer permits login for its corresponding third-party service) and/or to repair the SSO integration.
Patent NZ-738135-A (NZ)
Title: Collapsible fishing trap and a method of its use
Inventor: Cody Adam Burdis
IPC: A01K69/10
Filed: 2016-12-08
Abstract: The invention is a collapsible fishing trap (and a method of its manufacture and use) which is formed from a series of frames, wherein at least some of the frames themselves are constructed from individual lengths which are linked to each other such that they can be pivoted. This is so that the individual frames can be raised and lowered when the trap is erected or collapsed in use. This is advantageous for when retrieving the trap, the relevant frame members effectively collapse upon themselves and therefore can be wound up onto conventional drums that are often used on commercial fishing boats. This also means that relatively long fishing traps can be constructed and practically used while taking up less storage space relative to conventional, fixed frame, traps.
Patent NZ-768109-A (NZ)
Title: Case frame and door assembly for a merchandiser
Inventor: TWOHY RAYMOND
IPC: A47F3/00
Filed: 2016-10-26
Abstract: A mullion assembly 102 for a merchandiser, the mullion assembly 102 comprising an elongated mullion body 106 including a first end and a second end, the mullion body defining an elongated channel 186 extending from the first end toward the second end along a longitudinal axis oriented along a length of the mullion body, the channel 186 located adjacent a center of the mullion body and defined by a support surface 162, a light assembly coupled to the mullion body within the channel; and a heater coupled to the mullion body and positioned between the mullion body and the light assembly in direct contact with the light assembly, the light assembly and the heater positioned and configured to cooperatively heat the mullion body. The light assembly illuminates the items in the merchandiser, and the heater provides heat (or additional heat to supplement heat from the light assembly) to minimize or limit condensation that may form on the mullion and/or related parts.
Patent PT-103439-A (PT)
Title: Desobstruidor pneumático com vibração para desentupimento de esgotos gerais
Inventor: SARAIVA ANGELINO AUGUSTO
IPC: B08B9/047
Filed: 2006-02-22
Abstract: A PRESENTE INVENÇÃO REFERE-SE A UM DESOBSTRUIDOR PNEUMÁTICO COM VIBRAÇÃO PARA DESENTUPIMENTO DE ESGOTOS GERAIS, CONSTITUÍDO, ESSENCIALMENTE, POR UM VIBRADOR PNEUMÁTICO (FIG. 1) E UM VIBRADOR PNEUMÁTICO COM PERFURADOR (FIG. 2), FUNCIONANDO A AR COMPRIMIDO OU ENERGIA ELÉCTRICA, QUE PODEM SER FACILMENTE INTRODUZIDOS EM MANILHAS OU TUBOS OBSTRUÍDOS, PERMITINDO EFECTUAR O DESENTUPIMENTO DOS MESMOS, UTILIZANDO-SE O VIBRADOR PNEUMÁTICO QUANDO A OBSTRUÇÃO SEJA PROVOCADA POR MATERIAIS MUITO DUROS, POR EXEMPLO, PRODUTOS QUÍMICOS SOLIDIFICADOS OU PEDRAS, E O VIBRADOR PNEUMÁTICO COM PERFURADOR PARA CASOS DE ENTUPIMENTO COM DETRITOS POUCO CONSISTENTES, TAIS COMO LAMAS, LODOS OU AREIAS.
Patent PT-107925-A (PT)
Title: Tratamento de combinação de daa (eg. com abt-072 ou abt-333) para utilização no tratamento de hcv
Inventor: BERNSTEIN BARRY M
IPC: A61K45/06
Filed: 2012-10-19
Abstract: A PRESENTE INVENÇÃO APRESENTA TERAPIAS SEM INTERFERÃO E SEM RIBAVIRINA PARA O TRATAMENTO DE HCV. PREFERIVELMENTE, O TRATAMENTO TEM UMA DURAÇÃO DE TRATAMENTO MAIS CURTA, TAL COMO NÃO MAIS DE 12 SEMANAS. NUM ASPECTO, AS TERAPIAS COMPREENDEM A ADMINISTRAÇÃO DE PELO MENOS DOIS AGENTES ANTIVIRAIS DE ACTUAÇÃO DIRECTA SEM INTERFERÃO E SEM RIBAVIRINA A UM INDIVÍDUO COM INFECÇÃO POR HCV. POR EXEMPLO, AS TERAPIAS COMPREENDEM A ADMINISTRAÇÃO A UM INDIVÍDUO DE UMA QUANTIDADE EFICAZ DE AGENTE TERAPÊUTICO 1 (ABT) OU DE AGENTE TERAPÊUTICO 2 (=ABT-333) OU DE AGENTE TERAPÊUTICO 3 (=ABT-072) OU AGENTE TERAPÊUTICO 4 (ABT), E UM INIBIDOR DE CITOCROMO P450 (E.G., RITONAVIR).